Abstract
Pancreatitis is a life‐threatening inflammatory disease of the pancreas. The cytokine interleukin‐1α has been demonstrated to act as an alarmin released by necrotic cells. In the present study, we investigated the influence of IL‐1α on the immune response during acute and chronic pancreatitis. Following tissue injury, pancreatic acinar cells released IL‐1α, which activates tissue‐resident fibroblasts to differentiate toward a pro‐inflammatory phenotype. By secreting chemokines and cytokines such as CXCL5, CCL2, and IL‐6, these fibroblasts recruit immune cells to the pancreas. The absence of IL‐1α reduces disease severity in acute pancreatitis and chemokine release. Furthermore, IL‐1α primes fibroblasts to enhance the production of extracellular matrix‐components by the up‐regulation of pro‐fibrotic receptors such as Il4ra , Il13ra1 , and Tgfbr3 . Therefore, the deletion of IL‐1α significantly reduced the development of tissue fibrosis. A therapeutic blockade of the IL1R1‐signaling by i.p. administration of the IL‐1‐receptor antagonist Anakinra showed the same effect; the severity of acute pancreatitis and fibrogenesis during chronic pancreatitis were reduced. In conclusion, the crosstalk between necrotic acinar cells and fibroblasts mediated by IL‐1α plays a crucial role in acute inflammation of the pancreas and fibrogenic signaling. Blockade of IL1R1‐signaling by Anakinra is therefore a promising therapeutic intervention for both acute and chronic pancreatitis.
Funding Information
  • Deutsche Forschungsgemeinschaft (DFG SE 2702/2‐3)
  • Deutsche Forschungsgemeinschaft (DFG SE 2702/4‐1)
  • Deutsche Forschungsgemeinschaft (GL 1096/1‐1)
  • Deutsche Forschungsgemeinschaft (ZI 2071/2‐1)
  • Deutsche Forschungsgemeinschaft (GRK 2719 A1 C1)
  • Deutsche Forschungsgemeinschaft (RTG 2901 SYLOBIO)

This publication has 33 references indexed in Scilit: